Pee test could spot colon cancer early in africa
NCT ID NCT07649057
First seen Jun 20, 2026 · Last updated Jun 20, 2026
Summary
This study is testing a new urine test that aims to detect colorectal cancer and precancerous polyps early. Researchers will enroll 210 people in Ghana, Tanzania, and South Africa who have symptoms like rectal bleeding or are getting a colonoscopy. The test uses a biosensor to find three specific substances in urine, and the goal is to see if it works as well as earlier results from Nigeria, which showed 90% accuracy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kilimanjaro Christian Medical Centre (Data Collection Only)
NOT_YET_RECRUITINGMoshi, Tanzania
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Korle Bu Teaching Hospital (Data Collection Only)
NOT_YET_RECRUITINGAccra, Ghana
Contact Email: •••••@•••••
-
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
RECRUITINGNew York, New York, 10065, United States
Contact Phone: •••-•••-••••
-
Wits Donald Gordon Medical Centre (Data Collection Only)
NOT_YET_RECRUITINGJohannesburg, South Africa
Contact Phone: •••-•••-••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
3-metabolite biosensor (urine test)
What this could lead to
If successful, this could provide a simple, non-invasive urine test for early detection of colorectal cancer in Africa, improving survival rates.
What could go wrong
This is a validation study in specific African regions; results may not generalize elsewhere. The test's accuracy may be lower than hoped, and it is not yet a standard screening tool.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.